Global Neisseria Meningitidis Infections Drug Market Research Report 2025(Status and Outlook)
Report Overview
The global Neisseria Meningitidis Infections Drug market size was estimated at USD 452.8 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neisseria Meningitidis Infections Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neisseria Meningitidis Infections Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neisseria Meningitidis Infections Drug market
Global Neisseria Meningitidis Infections Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Market Segmentation (by Type)
MGBBP-3
NCL-195
TP-10
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neisseria Meningitidis Infections Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neisseria Meningitidis Infections Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Neisseria Meningitidis Infections Drug market size was estimated at USD 452.8 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 4.75% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Neisseria Meningitidis Infections Drug market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Neisseria Meningitidis Infections Drug market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Neisseria Meningitidis Infections Drug market
Global Neisseria Meningitidis Infections Drug Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Beijing Minhai Biotechnology Co Ltd
Biological E Ltd
China National Pharmaceutical Group Corp
GlaxoSmithKline Plc
Griffith University
ImmunoBiology Ltd
JN-International Medical Corp
MGB Biopharma Ltd
Panacea Biotec Ltd
Pfizer Inc
Sanofi Pasteur SA
Serum Institute of India Ltd
Wellstat Vaccines LLC
Market Segmentation (by Type)
MGBBP-3
NCL-195
TP-10
Others
Market Segmentation (by Application)
Hospital
Clinic
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Neisseria Meningitidis Infections Drug Market
- Overview of the regional outlook of the Neisseria Meningitidis Infections Drug Market.
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Neisseria Meningitidis Infections Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Neisseria Meningitidis Infections Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Neisseria Meningitidis Infections Drug
1.2 Key Market Segments
1.2.1 Neisseria Meningitidis Infections Drug Segment by Type
1.2.2 Neisseria Meningitidis Infections Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neisseria Meningitidis Infections Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Neisseria Meningitidis Infections Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neisseria Meningitidis Infections Drug Product Life Cycle
3.3 Global Neisseria Meningitidis Infections Drug Sales by Manufacturers (2020-2025)
3.4 Global Neisseria Meningitidis Infections Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Neisseria Meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neisseria Meningitidis Infections Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neisseria Meningitidis Infections Drug Market Competitive Situation and Trends
3.8.1 Neisseria Meningitidis Infections Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neisseria Meningitidis Infections Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEISSERIA MENINGITIDIS INFECTIONS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Neisseria Meningitidis Infections Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neisseria Meningitidis Infections Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neisseria Meningitidis Infections Drug Market
5.7 ESG Ratings of Leading Companies
6 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neisseria Meningitidis Infections Drug Sales Market Share by Type (2020-2025)
6.3 Global Neisseria Meningitidis Infections Drug Market Size Market Share by Type (2020-2025)
6.4 Global Neisseria Meningitidis Infections Drug Price by Type (2020-2025)
7 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neisseria Meningitidis Infections Drug Market Sales by Application (2020-2025)
7.3 Global Neisseria Meningitidis Infections Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Neisseria Meningitidis Infections Drug Sales Growth Rate by Application (2020-2025)
8 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SALES BY REGION
8.1 Global Neisseria Meningitidis Infections Drug Sales by Region
8.1.1 Global Neisseria Meningitidis Infections Drug Sales by Region
8.1.2 Global Neisseria Meningitidis Infections Drug Sales Market Share by Region
8.2 Global Neisseria Meningitidis Infections Drug Market Size by Region
8.2.1 Global Neisseria Meningitidis Infections Drug Market Size by Region
8.2.2 Global Neisseria Meningitidis Infections Drug Market Size Market Share by Region
8.3 North America
8.3.1 North America Neisseria Meningitidis Infections Drug Sales by Country
8.3.2 North America Neisseria Meningitidis Infections Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neisseria Meningitidis Infections Drug Sales by Country
8.4.2 Europe Neisseria Meningitidis Infections Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neisseria Meningitidis Infections Drug Sales by Region
8.5.2 Asia Pacific Neisseria Meningitidis Infections Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neisseria Meningitidis Infections Drug Sales by Country
8.6.2 South America Neisseria Meningitidis Infections Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neisseria Meningitidis Infections Drug Sales by Region
8.7.2 Middle East and Africa Neisseria Meningitidis Infections Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Neisseria Meningitidis Infections Drug by Region(2020-2025)
9.2 Global Neisseria Meningitidis Infections Drug Revenue Market Share by Region (2020-2025)
9.3 Global Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neisseria Meningitidis Infections Drug Production
9.4.1 North America Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.4.2 North America Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neisseria Meningitidis Infections Drug Production
9.5.1 Europe Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.5.2 Europe Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neisseria Meningitidis Infections Drug Production (2020-2025)
9.6.1 Japan Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.6.2 Japan Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neisseria Meningitidis Infections Drug Production (2020-2025)
9.7.1 China Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.7.2 China Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Beijing Minhai Biotechnology Co Ltd
10.1.1 Beijing Minhai Biotechnology Co Ltd Basic Information
10.1.2 Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Product Overview
10.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.1.4 Beijing Minhai Biotechnology Co Ltd Business Overview
10.1.5 Beijing Minhai Biotechnology Co Ltd SWOT Analysis
10.1.6 Beijing Minhai Biotechnology Co Ltd Recent Developments
10.2 Biological E Ltd
10.2.1 Biological E Ltd Basic Information
10.2.2 Biological E Ltd Neisseria Meningitidis Infections Drug Product Overview
10.2.3 Biological E Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.2.4 Biological E Ltd Business Overview
10.2.5 Biological E Ltd SWOT Analysis
10.2.6 Biological E Ltd Recent Developments
10.3 China National Pharmaceutical Group Corp
10.3.1 China National Pharmaceutical Group Corp Basic Information
10.3.2 China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Product Overview
10.3.3 China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Product Market Performance
10.3.4 China National Pharmaceutical Group Corp Business Overview
10.3.5 China National Pharmaceutical Group Corp SWOT Analysis
10.3.6 China National Pharmaceutical Group Corp Recent Developments
10.4 GlaxoSmithKline Plc
10.4.1 GlaxoSmithKline Plc Basic Information
10.4.2 GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Product Overview
10.4.3 GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Product Market Performance
10.4.4 GlaxoSmithKline Plc Business Overview
10.4.5 GlaxoSmithKline Plc Recent Developments
10.5 Griffith University
10.5.1 Griffith University Basic Information
10.5.2 Griffith University Neisseria Meningitidis Infections Drug Product Overview
10.5.3 Griffith University Neisseria Meningitidis Infections Drug Product Market Performance
10.5.4 Griffith University Business Overview
10.5.5 Griffith University Recent Developments
10.6 ImmunoBiology Ltd
10.6.1 ImmunoBiology Ltd Basic Information
10.6.2 ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Product Overview
10.6.3 ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.6.4 ImmunoBiology Ltd Business Overview
10.6.5 ImmunoBiology Ltd Recent Developments
10.7 JN-International Medical Corp
10.7.1 JN-International Medical Corp Basic Information
10.7.2 JN-International Medical Corp Neisseria Meningitidis Infections Drug Product Overview
10.7.3 JN-International Medical Corp Neisseria Meningitidis Infections Drug Product Market Performance
10.7.4 JN-International Medical Corp Business Overview
10.7.5 JN-International Medical Corp Recent Developments
10.8 MGB Biopharma Ltd
10.8.1 MGB Biopharma Ltd Basic Information
10.8.2 MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Product Overview
10.8.3 MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.8.4 MGB Biopharma Ltd Business Overview
10.8.5 MGB Biopharma Ltd Recent Developments
10.9 Panacea Biotec Ltd
10.9.1 Panacea Biotec Ltd Basic Information
10.9.2 Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Product Overview
10.9.3 Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.9.4 Panacea Biotec Ltd Business Overview
10.9.5 Panacea Biotec Ltd Recent Developments
10.10 Pfizer Inc
10.10.1 Pfizer Inc Basic Information
10.10.2 Pfizer Inc Neisseria Meningitidis Infections Drug Product Overview
10.10.3 Pfizer Inc Neisseria Meningitidis Infections Drug Product Market Performance
10.10.4 Pfizer Inc Business Overview
10.10.5 Pfizer Inc Recent Developments
10.11 Sanofi Pasteur SA
10.11.1 Sanofi Pasteur SA Basic Information
10.11.2 Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Product Overview
10.11.3 Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Product Market Performance
10.11.4 Sanofi Pasteur SA Business Overview
10.11.5 Sanofi Pasteur SA Recent Developments
10.12 Serum Institute of India Ltd
10.12.1 Serum Institute of India Ltd Basic Information
10.12.2 Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Product Overview
10.12.3 Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.12.4 Serum Institute of India Ltd Business Overview
10.12.5 Serum Institute of India Ltd Recent Developments
10.13 Wellstat Vaccines LLC
10.13.1 Wellstat Vaccines LLC Basic Information
10.13.2 Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Product Overview
10.13.3 Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Product Market Performance
10.13.4 Wellstat Vaccines LLC Business Overview
10.13.5 Wellstat Vaccines LLC Recent Developments
11 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET FORECAST BY REGION
11.1 Global Neisseria Meningitidis Infections Drug Market Size Forecast
11.2 Global Neisseria Meningitidis Infections Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neisseria Meningitidis Infections Drug Market Size Forecast by Country
11.2.3 Asia Pacific Neisseria Meningitidis Infections Drug Market Size Forecast by Region
11.2.4 South America Neisseria Meningitidis Infections Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neisseria Meningitidis Infections Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Neisseria Meningitidis Infections Drug Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Neisseria Meningitidis Infections Drug by Type (2026-2033)
12.1.2 Global Neisseria Meningitidis Infections Drug Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Neisseria Meningitidis Infections Drug by Type (2026-2033)
12.2 Global Neisseria Meningitidis Infections Drug Market Forecast by Application (2026-2033)
12.2.1 Global Neisseria Meningitidis Infections Drug Sales (K MT) Forecast by Application
12.2.2 Global Neisseria Meningitidis Infections Drug Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Neisseria Meningitidis Infections Drug
1.2 Key Market Segments
1.2.1 Neisseria Meningitidis Infections Drug Segment by Type
1.2.2 Neisseria Meningitidis Infections Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Neisseria Meningitidis Infections Drug Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Neisseria Meningitidis Infections Drug Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Neisseria Meningitidis Infections Drug Product Life Cycle
3.3 Global Neisseria Meningitidis Infections Drug Sales by Manufacturers (2020-2025)
3.4 Global Neisseria Meningitidis Infections Drug Revenue Market Share by Manufacturers (2020-2025)
3.5 Neisseria Meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Neisseria Meningitidis Infections Drug Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Neisseria Meningitidis Infections Drug Market Competitive Situation and Trends
3.8.1 Neisseria Meningitidis Infections Drug Market Concentration Rate
3.8.2 Global 5 and 10 Largest Neisseria Meningitidis Infections Drug Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NEISSERIA MENINGITIDIS INFECTIONS DRUG INDUSTRY CHAIN ANALYSIS
4.1 Neisseria Meningitidis Infections Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Neisseria Meningitidis Infections Drug Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Neisseria Meningitidis Infections Drug Market
5.7 ESG Ratings of Leading Companies
6 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neisseria Meningitidis Infections Drug Sales Market Share by Type (2020-2025)
6.3 Global Neisseria Meningitidis Infections Drug Market Size Market Share by Type (2020-2025)
6.4 Global Neisseria Meningitidis Infections Drug Price by Type (2020-2025)
7 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neisseria Meningitidis Infections Drug Market Sales by Application (2020-2025)
7.3 Global Neisseria Meningitidis Infections Drug Market Size (M USD) by Application (2020-2025)
7.4 Global Neisseria Meningitidis Infections Drug Sales Growth Rate by Application (2020-2025)
8 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET SALES BY REGION
8.1 Global Neisseria Meningitidis Infections Drug Sales by Region
8.1.1 Global Neisseria Meningitidis Infections Drug Sales by Region
8.1.2 Global Neisseria Meningitidis Infections Drug Sales Market Share by Region
8.2 Global Neisseria Meningitidis Infections Drug Market Size by Region
8.2.1 Global Neisseria Meningitidis Infections Drug Market Size by Region
8.2.2 Global Neisseria Meningitidis Infections Drug Market Size Market Share by Region
8.3 North America
8.3.1 North America Neisseria Meningitidis Infections Drug Sales by Country
8.3.2 North America Neisseria Meningitidis Infections Drug Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Neisseria Meningitidis Infections Drug Sales by Country
8.4.2 Europe Neisseria Meningitidis Infections Drug Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Neisseria Meningitidis Infections Drug Sales by Region
8.5.2 Asia Pacific Neisseria Meningitidis Infections Drug Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Neisseria Meningitidis Infections Drug Sales by Country
8.6.2 South America Neisseria Meningitidis Infections Drug Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Neisseria Meningitidis Infections Drug Sales by Region
8.7.2 Middle East and Africa Neisseria Meningitidis Infections Drug Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET PRODUCTION BY REGION
9.1 Global Production of Neisseria Meningitidis Infections Drug by Region(2020-2025)
9.2 Global Neisseria Meningitidis Infections Drug Revenue Market Share by Region (2020-2025)
9.3 Global Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Neisseria Meningitidis Infections Drug Production
9.4.1 North America Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.4.2 North America Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Neisseria Meningitidis Infections Drug Production
9.5.1 Europe Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.5.2 Europe Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Neisseria Meningitidis Infections Drug Production (2020-2025)
9.6.1 Japan Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.6.2 Japan Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Neisseria Meningitidis Infections Drug Production (2020-2025)
9.7.1 China Neisseria Meningitidis Infections Drug Production Growth Rate (2020-2025)
9.7.2 China Neisseria Meningitidis Infections Drug Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Beijing Minhai Biotechnology Co Ltd
10.1.1 Beijing Minhai Biotechnology Co Ltd Basic Information
10.1.2 Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Product Overview
10.1.3 Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.1.4 Beijing Minhai Biotechnology Co Ltd Business Overview
10.1.5 Beijing Minhai Biotechnology Co Ltd SWOT Analysis
10.1.6 Beijing Minhai Biotechnology Co Ltd Recent Developments
10.2 Biological E Ltd
10.2.1 Biological E Ltd Basic Information
10.2.2 Biological E Ltd Neisseria Meningitidis Infections Drug Product Overview
10.2.3 Biological E Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.2.4 Biological E Ltd Business Overview
10.2.5 Biological E Ltd SWOT Analysis
10.2.6 Biological E Ltd Recent Developments
10.3 China National Pharmaceutical Group Corp
10.3.1 China National Pharmaceutical Group Corp Basic Information
10.3.2 China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Product Overview
10.3.3 China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Product Market Performance
10.3.4 China National Pharmaceutical Group Corp Business Overview
10.3.5 China National Pharmaceutical Group Corp SWOT Analysis
10.3.6 China National Pharmaceutical Group Corp Recent Developments
10.4 GlaxoSmithKline Plc
10.4.1 GlaxoSmithKline Plc Basic Information
10.4.2 GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Product Overview
10.4.3 GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Product Market Performance
10.4.4 GlaxoSmithKline Plc Business Overview
10.4.5 GlaxoSmithKline Plc Recent Developments
10.5 Griffith University
10.5.1 Griffith University Basic Information
10.5.2 Griffith University Neisseria Meningitidis Infections Drug Product Overview
10.5.3 Griffith University Neisseria Meningitidis Infections Drug Product Market Performance
10.5.4 Griffith University Business Overview
10.5.5 Griffith University Recent Developments
10.6 ImmunoBiology Ltd
10.6.1 ImmunoBiology Ltd Basic Information
10.6.2 ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Product Overview
10.6.3 ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.6.4 ImmunoBiology Ltd Business Overview
10.6.5 ImmunoBiology Ltd Recent Developments
10.7 JN-International Medical Corp
10.7.1 JN-International Medical Corp Basic Information
10.7.2 JN-International Medical Corp Neisseria Meningitidis Infections Drug Product Overview
10.7.3 JN-International Medical Corp Neisseria Meningitidis Infections Drug Product Market Performance
10.7.4 JN-International Medical Corp Business Overview
10.7.5 JN-International Medical Corp Recent Developments
10.8 MGB Biopharma Ltd
10.8.1 MGB Biopharma Ltd Basic Information
10.8.2 MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Product Overview
10.8.3 MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.8.4 MGB Biopharma Ltd Business Overview
10.8.5 MGB Biopharma Ltd Recent Developments
10.9 Panacea Biotec Ltd
10.9.1 Panacea Biotec Ltd Basic Information
10.9.2 Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Product Overview
10.9.3 Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.9.4 Panacea Biotec Ltd Business Overview
10.9.5 Panacea Biotec Ltd Recent Developments
10.10 Pfizer Inc
10.10.1 Pfizer Inc Basic Information
10.10.2 Pfizer Inc Neisseria Meningitidis Infections Drug Product Overview
10.10.3 Pfizer Inc Neisseria Meningitidis Infections Drug Product Market Performance
10.10.4 Pfizer Inc Business Overview
10.10.5 Pfizer Inc Recent Developments
10.11 Sanofi Pasteur SA
10.11.1 Sanofi Pasteur SA Basic Information
10.11.2 Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Product Overview
10.11.3 Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Product Market Performance
10.11.4 Sanofi Pasteur SA Business Overview
10.11.5 Sanofi Pasteur SA Recent Developments
10.12 Serum Institute of India Ltd
10.12.1 Serum Institute of India Ltd Basic Information
10.12.2 Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Product Overview
10.12.3 Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Product Market Performance
10.12.4 Serum Institute of India Ltd Business Overview
10.12.5 Serum Institute of India Ltd Recent Developments
10.13 Wellstat Vaccines LLC
10.13.1 Wellstat Vaccines LLC Basic Information
10.13.2 Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Product Overview
10.13.3 Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Product Market Performance
10.13.4 Wellstat Vaccines LLC Business Overview
10.13.5 Wellstat Vaccines LLC Recent Developments
11 NEISSERIA MENINGITIDIS INFECTIONS DRUG MARKET FORECAST BY REGION
11.1 Global Neisseria Meningitidis Infections Drug Market Size Forecast
11.2 Global Neisseria Meningitidis Infections Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Neisseria Meningitidis Infections Drug Market Size Forecast by Country
11.2.3 Asia Pacific Neisseria Meningitidis Infections Drug Market Size Forecast by Region
11.2.4 South America Neisseria Meningitidis Infections Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Neisseria Meningitidis Infections Drug by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Neisseria Meningitidis Infections Drug Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Neisseria Meningitidis Infections Drug by Type (2026-2033)
12.1.2 Global Neisseria Meningitidis Infections Drug Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Neisseria Meningitidis Infections Drug by Type (2026-2033)
12.2 Global Neisseria Meningitidis Infections Drug Market Forecast by Application (2026-2033)
12.2.1 Global Neisseria Meningitidis Infections Drug Sales (K MT) Forecast by Application
12.2.2 Global Neisseria Meningitidis Infections Drug Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neisseria Meningitidis Infections Drug Market Size Comparison by Region (M USD)
Table 5. Global Neisseria Meningitidis Infections Drug Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Neisseria Meningitidis Infections Drug Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Neisseria Meningitidis Infections Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Neisseria Meningitidis Infections Drug Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neisseria Meningitidis Infections Drug as of 2024)
Table 10. Global Market Neisseria Meningitidis Infections Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Neisseria Meningitidis Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Neisseria Meningitidis Infections Drug Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Neisseria Meningitidis Infections Drug Sales by Type (K MT)
Table 26. Global Neisseria Meningitidis Infections Drug Market Size by Type (M USD)
Table 27. Global Neisseria Meningitidis Infections Drug Sales (K MT) by Type (2020-2025)
Table 28. Global Neisseria Meningitidis Infections Drug Sales Market Share by Type (2020-2025)
Table 29. Global Neisseria Meningitidis Infections Drug Market Size (M USD) by Type (2020-2025)
Table 30. Global Neisseria Meningitidis Infections Drug Market Size Share by Type (2020-2025)
Table 31. Global Neisseria Meningitidis Infections Drug Price (USD/KG) by Type (2020-2025)
Table 32. Global Neisseria Meningitidis Infections Drug Sales (K MT) by Application
Table 33. Global Neisseria Meningitidis Infections Drug Market Size by Application
Table 34. Global Neisseria Meningitidis Infections Drug Sales by Application (2020-2025) & (K MT)
Table 35. Global Neisseria Meningitidis Infections Drug Sales Market Share by Application (2020-2025)
Table 36. Global Neisseria Meningitidis Infections Drug Market Size by Application (2020-2025) & (M USD)
Table 37. Global Neisseria Meningitidis Infections Drug Market Share by Application (2020-2025)
Table 38. Global Neisseria Meningitidis Infections Drug Sales Growth Rate by Application (2020-2025)
Table 39. Global Neisseria Meningitidis Infections Drug Sales by Region (2020-2025) & (K MT)
Table 40. Global Neisseria Meningitidis Infections Drug Sales Market Share by Region (2020-2025)
Table 41. Global Neisseria Meningitidis Infections Drug Market Size by Region (2020-2025) & (M USD)
Table 42. Global Neisseria Meningitidis Infections Drug Market Size Market Share by Region (2020-2025)
Table 43. North America Neisseria Meningitidis Infections Drug Sales by Country (2020-2025) & (K MT)
Table 44. North America Neisseria Meningitidis Infections Drug Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Neisseria Meningitidis Infections Drug Sales by Country (2020-2025) & (K MT)
Table 46. Europe Neisseria Meningitidis Infections Drug Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Neisseria Meningitidis Infections Drug Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Neisseria Meningitidis Infections Drug Market Size by Region (2020-2025) & (M USD)
Table 49. South America Neisseria Meningitidis Infections Drug Sales by Country (2020-2025) & (K MT)
Table 50. South America Neisseria Meningitidis Infections Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Neisseria Meningitidis Infections Drug Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size by Region (2020-2025) & (M USD)
Table 53. Global Neisseria Meningitidis Infections Drug Production (K MT) by Region(2020-2025)
Table 54. Global Neisseria Meningitidis Infections Drug Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Neisseria Meningitidis Infections Drug Revenue Market Share by Region (2020-2025)
Table 56. Global Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Beijing Minhai Biotechnology Co Ltd Basic Information
Table 62. Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 63. Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Beijing Minhai Biotechnology Co Ltd Business Overview
Table 65. Beijing Minhai Biotechnology Co Ltd SWOT Analysis
Table 66. Beijing Minhai Biotechnology Co Ltd Recent Developments
Table 67. Biological E Ltd Basic Information
Table 68. Biological E Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 69. Biological E Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Biological E Ltd Business Overview
Table 71. Biological E Ltd SWOT Analysis
Table 72. Biological E Ltd Recent Developments
Table 73. China National Pharmaceutical Group Corp Basic Information
Table 74. China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Product Overview
Table 75. China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. China National Pharmaceutical Group Corp Business Overview
Table 77. China National Pharmaceutical Group Corp SWOT Analysis
Table 78. China National Pharmaceutical Group Corp Recent Developments
Table 79. GlaxoSmithKline Plc Basic Information
Table 80. GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Product Overview
Table 81. GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. GlaxoSmithKline Plc Business Overview
Table 83. GlaxoSmithKline Plc Recent Developments
Table 84. Griffith University Basic Information
Table 85. Griffith University Neisseria Meningitidis Infections Drug Product Overview
Table 86. Griffith University Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Griffith University Business Overview
Table 88. Griffith University Recent Developments
Table 89. ImmunoBiology Ltd Basic Information
Table 90. ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 91. ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. ImmunoBiology Ltd Business Overview
Table 93. ImmunoBiology Ltd Recent Developments
Table 94. JN-International Medical Corp Basic Information
Table 95. JN-International Medical Corp Neisseria Meningitidis Infections Drug Product Overview
Table 96. JN-International Medical Corp Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. JN-International Medical Corp Business Overview
Table 98. JN-International Medical Corp Recent Developments
Table 99. MGB Biopharma Ltd Basic Information
Table 100. MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 101. MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. MGB Biopharma Ltd Business Overview
Table 103. MGB Biopharma Ltd Recent Developments
Table 104. Panacea Biotec Ltd Basic Information
Table 105. Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 106. Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Panacea Biotec Ltd Business Overview
Table 108. Panacea Biotec Ltd Recent Developments
Table 109. Pfizer Inc Basic Information
Table 110. Pfizer Inc Neisseria Meningitidis Infections Drug Product Overview
Table 111. Pfizer Inc Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Pfizer Inc Business Overview
Table 113. Pfizer Inc Recent Developments
Table 114. Sanofi Pasteur SA Basic Information
Table 115. Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Product Overview
Table 116. Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Sanofi Pasteur SA Business Overview
Table 118. Sanofi Pasteur SA Recent Developments
Table 119. Serum Institute of India Ltd Basic Information
Table 120. Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 121. Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Serum Institute of India Ltd Business Overview
Table 123. Serum Institute of India Ltd Recent Developments
Table 124. Wellstat Vaccines LLC Basic Information
Table 125. Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Product Overview
Table 126. Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Wellstat Vaccines LLC Business Overview
Table 128. Wellstat Vaccines LLC Recent Developments
Table 129. Global Neisseria Meningitidis Infections Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 132. North America Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 134. Europe Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Neisseria Meningitidis Infections Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 136. Asia Pacific Neisseria Meningitidis Infections Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 138. South America Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Neisseria Meningitidis Infections Drug Sales Forecast by Type (2026-2033) & (K MT)
Table 142. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Neisseria Meningitidis Infections Drug Price Forecast by Type (2026-2033) & (USD/KG)
Table 144. Global Neisseria Meningitidis Infections Drug Sales (K MT) Forecast by Application (2026-2033)
Table 145. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Neisseria Meningitidis Infections Drug Market Size Comparison by Region (M USD)
Table 5. Global Neisseria Meningitidis Infections Drug Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Neisseria Meningitidis Infections Drug Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Neisseria Meningitidis Infections Drug Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Neisseria Meningitidis Infections Drug Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neisseria Meningitidis Infections Drug as of 2024)
Table 10. Global Market Neisseria Meningitidis Infections Drug Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Neisseria Meningitidis Infections Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Neisseria Meningitidis Infections Drug Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Neisseria Meningitidis Infections Drug Sales by Type (K MT)
Table 26. Global Neisseria Meningitidis Infections Drug Market Size by Type (M USD)
Table 27. Global Neisseria Meningitidis Infections Drug Sales (K MT) by Type (2020-2025)
Table 28. Global Neisseria Meningitidis Infections Drug Sales Market Share by Type (2020-2025)
Table 29. Global Neisseria Meningitidis Infections Drug Market Size (M USD) by Type (2020-2025)
Table 30. Global Neisseria Meningitidis Infections Drug Market Size Share by Type (2020-2025)
Table 31. Global Neisseria Meningitidis Infections Drug Price (USD/KG) by Type (2020-2025)
Table 32. Global Neisseria Meningitidis Infections Drug Sales (K MT) by Application
Table 33. Global Neisseria Meningitidis Infections Drug Market Size by Application
Table 34. Global Neisseria Meningitidis Infections Drug Sales by Application (2020-2025) & (K MT)
Table 35. Global Neisseria Meningitidis Infections Drug Sales Market Share by Application (2020-2025)
Table 36. Global Neisseria Meningitidis Infections Drug Market Size by Application (2020-2025) & (M USD)
Table 37. Global Neisseria Meningitidis Infections Drug Market Share by Application (2020-2025)
Table 38. Global Neisseria Meningitidis Infections Drug Sales Growth Rate by Application (2020-2025)
Table 39. Global Neisseria Meningitidis Infections Drug Sales by Region (2020-2025) & (K MT)
Table 40. Global Neisseria Meningitidis Infections Drug Sales Market Share by Region (2020-2025)
Table 41. Global Neisseria Meningitidis Infections Drug Market Size by Region (2020-2025) & (M USD)
Table 42. Global Neisseria Meningitidis Infections Drug Market Size Market Share by Region (2020-2025)
Table 43. North America Neisseria Meningitidis Infections Drug Sales by Country (2020-2025) & (K MT)
Table 44. North America Neisseria Meningitidis Infections Drug Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Neisseria Meningitidis Infections Drug Sales by Country (2020-2025) & (K MT)
Table 46. Europe Neisseria Meningitidis Infections Drug Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Neisseria Meningitidis Infections Drug Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Neisseria Meningitidis Infections Drug Market Size by Region (2020-2025) & (M USD)
Table 49. South America Neisseria Meningitidis Infections Drug Sales by Country (2020-2025) & (K MT)
Table 50. South America Neisseria Meningitidis Infections Drug Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Neisseria Meningitidis Infections Drug Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size by Region (2020-2025) & (M USD)
Table 53. Global Neisseria Meningitidis Infections Drug Production (K MT) by Region(2020-2025)
Table 54. Global Neisseria Meningitidis Infections Drug Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Neisseria Meningitidis Infections Drug Revenue Market Share by Region (2020-2025)
Table 56. Global Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Neisseria Meningitidis Infections Drug Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Beijing Minhai Biotechnology Co Ltd Basic Information
Table 62. Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 63. Beijing Minhai Biotechnology Co Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Beijing Minhai Biotechnology Co Ltd Business Overview
Table 65. Beijing Minhai Biotechnology Co Ltd SWOT Analysis
Table 66. Beijing Minhai Biotechnology Co Ltd Recent Developments
Table 67. Biological E Ltd Basic Information
Table 68. Biological E Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 69. Biological E Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Biological E Ltd Business Overview
Table 71. Biological E Ltd SWOT Analysis
Table 72. Biological E Ltd Recent Developments
Table 73. China National Pharmaceutical Group Corp Basic Information
Table 74. China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Product Overview
Table 75. China National Pharmaceutical Group Corp Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 76. China National Pharmaceutical Group Corp Business Overview
Table 77. China National Pharmaceutical Group Corp SWOT Analysis
Table 78. China National Pharmaceutical Group Corp Recent Developments
Table 79. GlaxoSmithKline Plc Basic Information
Table 80. GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Product Overview
Table 81. GlaxoSmithKline Plc Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 82. GlaxoSmithKline Plc Business Overview
Table 83. GlaxoSmithKline Plc Recent Developments
Table 84. Griffith University Basic Information
Table 85. Griffith University Neisseria Meningitidis Infections Drug Product Overview
Table 86. Griffith University Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 87. Griffith University Business Overview
Table 88. Griffith University Recent Developments
Table 89. ImmunoBiology Ltd Basic Information
Table 90. ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 91. ImmunoBiology Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 92. ImmunoBiology Ltd Business Overview
Table 93. ImmunoBiology Ltd Recent Developments
Table 94. JN-International Medical Corp Basic Information
Table 95. JN-International Medical Corp Neisseria Meningitidis Infections Drug Product Overview
Table 96. JN-International Medical Corp Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 97. JN-International Medical Corp Business Overview
Table 98. JN-International Medical Corp Recent Developments
Table 99. MGB Biopharma Ltd Basic Information
Table 100. MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 101. MGB Biopharma Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 102. MGB Biopharma Ltd Business Overview
Table 103. MGB Biopharma Ltd Recent Developments
Table 104. Panacea Biotec Ltd Basic Information
Table 105. Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 106. Panacea Biotec Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 107. Panacea Biotec Ltd Business Overview
Table 108. Panacea Biotec Ltd Recent Developments
Table 109. Pfizer Inc Basic Information
Table 110. Pfizer Inc Neisseria Meningitidis Infections Drug Product Overview
Table 111. Pfizer Inc Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 112. Pfizer Inc Business Overview
Table 113. Pfizer Inc Recent Developments
Table 114. Sanofi Pasteur SA Basic Information
Table 115. Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Product Overview
Table 116. Sanofi Pasteur SA Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 117. Sanofi Pasteur SA Business Overview
Table 118. Sanofi Pasteur SA Recent Developments
Table 119. Serum Institute of India Ltd Basic Information
Table 120. Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Product Overview
Table 121. Serum Institute of India Ltd Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 122. Serum Institute of India Ltd Business Overview
Table 123. Serum Institute of India Ltd Recent Developments
Table 124. Wellstat Vaccines LLC Basic Information
Table 125. Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Product Overview
Table 126. Wellstat Vaccines LLC Neisseria Meningitidis Infections Drug Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 127. Wellstat Vaccines LLC Business Overview
Table 128. Wellstat Vaccines LLC Recent Developments
Table 129. Global Neisseria Meningitidis Infections Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 130. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 131. North America Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 132. North America Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 133. Europe Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 134. Europe Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 135. Asia Pacific Neisseria Meningitidis Infections Drug Sales Forecast by Region (2026-2033) & (K MT)
Table 136. Asia Pacific Neisseria Meningitidis Infections Drug Market Size Forecast by Region (2026-2033) & (M USD)
Table 137. South America Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (K MT)
Table 138. South America Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 139. Middle East and Africa Neisseria Meningitidis Infections Drug Sales Forecast by Country (2026-2033) & (Units)
Table 140. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size Forecast by Country (2026-2033) & (M USD)
Table 141. Global Neisseria Meningitidis Infections Drug Sales Forecast by Type (2026-2033) & (K MT)
Table 142. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Type (2026-2033) & (M USD)
Table 143. Global Neisseria Meningitidis Infections Drug Price Forecast by Type (2026-2033) & (USD/KG)
Table 144. Global Neisseria Meningitidis Infections Drug Sales (K MT) Forecast by Application (2026-2033)
Table 145. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Neisseria Meningitidis Infections Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neisseria Meningitidis Infections Drug Market Size (M USD), 2024-2033
Figure 5. Global Neisseria Meningitidis Infections Drug Market Size (M USD) (2020-2033)
Figure 6. Global Neisseria Meningitidis Infections Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neisseria Meningitidis Infections Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neisseria Meningitidis Infections Drug Product Life Cycle
Figure 13. Neisseria Meningitidis Infections Drug Sales Share by Manufacturers in 2024
Figure 14. Global Neisseria Meningitidis Infections Drug Revenue Share by Manufacturers in 2024
Figure 15. Neisseria Meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neisseria Meningitidis Infections Drug Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neisseria Meningitidis Infections Drug Revenue in 2024
Figure 18. Industry Chain Map of Neisseria Meningitidis Infections Drug
Figure 19. Global Neisseria Meningitidis Infections Drug Market PEST Analysis
Figure 20. Global Neisseria Meningitidis Infections Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neisseria Meningitidis Infections Drug Market Share by Type
Figure 27. Sales Market Share of Neisseria Meningitidis Infections Drug by Type (2020-2025)
Figure 28. Sales Market Share of Neisseria Meningitidis Infections Drug by Type in 2024
Figure 29. Market Size Share of Neisseria Meningitidis Infections Drug by Type (2020-2025)
Figure 30. Market Size Share of Neisseria Meningitidis Infections Drug by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neisseria Meningitidis Infections Drug Market Share by Application
Figure 33. Global Neisseria Meningitidis Infections Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Neisseria Meningitidis Infections Drug Sales Market Share by Application in 2024
Figure 35. Global Neisseria Meningitidis Infections Drug Market Share by Application (2020-2025)
Figure 36. Global Neisseria Meningitidis Infections Drug Market Share by Application in 2024
Figure 37. Global Neisseria Meningitidis Infections Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neisseria Meningitidis Infections Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Neisseria Meningitidis Infections Drug Market Size Market Share by Region (2020-2025)
Figure 40. North America Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Neisseria Meningitidis Infections Drug Sales Market Share by Country in 2024
Figure 43. North America Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neisseria Meningitidis Infections Drug Market Size Market Share by Country in 2024
Figure 45. U.S. Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neisseria Meningitidis Infections Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Neisseria Meningitidis Infections Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neisseria Meningitidis Infections Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neisseria Meningitidis Infections Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Neisseria Meningitidis Infections Drug Sales Market Share by Country in 2024
Figure 53. Europe Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neisseria Meningitidis Infections Drug Market Size Market Share by Country in 2024
Figure 55. Germany Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neisseria Meningitidis Infections Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Neisseria Meningitidis Infections Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neisseria Meningitidis Infections Drug Market Size Market Share by Region in 2024
Figure 68. China Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neisseria Meningitidis Infections Drug Sales and Growth Rate (K MT)
Figure 79. South America Neisseria Meningitidis Infections Drug Sales Market Share by Country in 2024
Figure 80. South America Neisseria Meningitidis Infections Drug Market Size and Growth Rate (M USD)
Figure 81. South America Neisseria Meningitidis Infections Drug Market Size Market Share by Country in 2024
Figure 82. Brazil Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neisseria Meningitidis Infections Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Neisseria Meningitidis Infections Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neisseria Meningitidis Infections Drug Production Market Share by Region (2020-2025)
Figure 103. North America Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Neisseria Meningitidis Infections Drug Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Neisseria Meningitidis Infections Drug Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Neisseria Meningitidis Infections Drug Market Share Forecast by Type (2026-2033)
Figure 111. Global Neisseria Meningitidis Infections Drug Sales Forecast by Application (2026-2033)
Figure 112. Global Neisseria Meningitidis Infections Drug Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Neisseria Meningitidis Infections Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Neisseria Meningitidis Infections Drug Market Size (M USD), 2024-2033
Figure 5. Global Neisseria Meningitidis Infections Drug Market Size (M USD) (2020-2033)
Figure 6. Global Neisseria Meningitidis Infections Drug Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Neisseria Meningitidis Infections Drug Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Neisseria Meningitidis Infections Drug Product Life Cycle
Figure 13. Neisseria Meningitidis Infections Drug Sales Share by Manufacturers in 2024
Figure 14. Global Neisseria Meningitidis Infections Drug Revenue Share by Manufacturers in 2024
Figure 15. Neisseria Meningitidis Infections Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Neisseria Meningitidis Infections Drug Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neisseria Meningitidis Infections Drug Revenue in 2024
Figure 18. Industry Chain Map of Neisseria Meningitidis Infections Drug
Figure 19. Global Neisseria Meningitidis Infections Drug Market PEST Analysis
Figure 20. Global Neisseria Meningitidis Infections Drug Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Neisseria Meningitidis Infections Drug Market Share by Type
Figure 27. Sales Market Share of Neisseria Meningitidis Infections Drug by Type (2020-2025)
Figure 28. Sales Market Share of Neisseria Meningitidis Infections Drug by Type in 2024
Figure 29. Market Size Share of Neisseria Meningitidis Infections Drug by Type (2020-2025)
Figure 30. Market Size Share of Neisseria Meningitidis Infections Drug by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Neisseria Meningitidis Infections Drug Market Share by Application
Figure 33. Global Neisseria Meningitidis Infections Drug Sales Market Share by Application (2020-2025)
Figure 34. Global Neisseria Meningitidis Infections Drug Sales Market Share by Application in 2024
Figure 35. Global Neisseria Meningitidis Infections Drug Market Share by Application (2020-2025)
Figure 36. Global Neisseria Meningitidis Infections Drug Market Share by Application in 2024
Figure 37. Global Neisseria Meningitidis Infections Drug Sales Growth Rate by Application (2020-2025)
Figure 38. Global Neisseria Meningitidis Infections Drug Sales Market Share by Region (2020-2025)
Figure 39. Global Neisseria Meningitidis Infections Drug Market Size Market Share by Region (2020-2025)
Figure 40. North America Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Neisseria Meningitidis Infections Drug Sales Market Share by Country in 2024
Figure 43. North America Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Neisseria Meningitidis Infections Drug Market Size Market Share by Country in 2024
Figure 45. U.S. Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Neisseria Meningitidis Infections Drug Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Neisseria Meningitidis Infections Drug Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Neisseria Meningitidis Infections Drug Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Neisseria Meningitidis Infections Drug Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Neisseria Meningitidis Infections Drug Sales Market Share by Country in 2024
Figure 53. Europe Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Neisseria Meningitidis Infections Drug Market Size Market Share by Country in 2024
Figure 55. Germany Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Neisseria Meningitidis Infections Drug Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Neisseria Meningitidis Infections Drug Sales Market Share by Region in 2024
Figure 67. Asia Pacific Neisseria Meningitidis Infections Drug Market Size Market Share by Region in 2024
Figure 68. China Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Neisseria Meningitidis Infections Drug Sales and Growth Rate (K MT)
Figure 79. South America Neisseria Meningitidis Infections Drug Sales Market Share by Country in 2024
Figure 80. South America Neisseria Meningitidis Infections Drug Market Size and Growth Rate (M USD)
Figure 81. South America Neisseria Meningitidis Infections Drug Market Size Market Share by Country in 2024
Figure 82. Brazil Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Neisseria Meningitidis Infections Drug Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Neisseria Meningitidis Infections Drug Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Neisseria Meningitidis Infections Drug Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Neisseria Meningitidis Infections Drug Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Neisseria Meningitidis Infections Drug Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Neisseria Meningitidis Infections Drug Production Market Share by Region (2020-2025)
Figure 103. North America Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 106. China Neisseria Meningitidis Infections Drug Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Neisseria Meningitidis Infections Drug Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Neisseria Meningitidis Infections Drug Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Neisseria Meningitidis Infections Drug Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Neisseria Meningitidis Infections Drug Market Share Forecast by Type (2026-2033)
Figure 111. Global Neisseria Meningitidis Infections Drug Sales Forecast by Application (2026-2033)
Figure 112. Global Neisseria Meningitidis Infections Drug Market Share Forecast by Application (2026-2033)
